Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Age at menopause is an important determinant of future health outcomes, but little is known about its relationship with type 2 diabetes. We examined the associations of menopausal age and reproductive life span (menopausal age minus menarcheal age) with diabetes risk. RESEARCH DESIGN AND METHODS: Data were obtained from the InterAct study, a prospective case-cohort study nested within the European Prospective Investigation into Cancer and Nutrition. A total of 3,691 postmenopausal type 2 diabetic case subjects and 4,408 subcohort members were included in the analysis, with a median follow-up of 11 years. Prentice weighted Cox proportional hazards models were adjusted for age, known risk factors for diabetes, and reproductive factors, and effect modification by BMI, waist circumference, and smoking was studied. RESULTS: Mean (SD) age of the subcohort was 59.2 (5.8) years. After multivariable adjustment, hazard ratios (HRs) of type 2 diabetes were 1.32 (95% CI 1.04–1.69), 1.09 (0.90–1.31), 0.97 (0.86–1.10), and 0.85 (0.70–1.03) for women with menopause at ages <40, 40–44, 45–49, and ≥55 years, respectively, relative to those with menopause at age 50–54 years. The HR per SD younger age at menopause was 1.08 (1.02–1.14). Similarly, a shorter reproductive life span was associated with a higher diabetes risk (HR per SD lower reproductive life span 1.06 [1.01–1.12]). No effect modification by BMI, waist circumference, or smoking was observed (P interaction all > 0.05). CONCLUSIONS: Early menopause is associated with a greater risk of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
for the Women’s Health Initiative Investigators, Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1448-x · Cited by 599 · cited 1×
“Mechanistic studies have demonstrated beneficial long-term effects of exogenous estrogens on insulin secretion and glucose homeostasis (33), and in postmenopausal women estrogen replacement has been associated with a lower incidence of type 2 diabetes (34,35).”
Must, A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.7.672 · Cited by 506
Burger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6740 · Cited by 439 · cited 1×
“The menopausal transition is also characterized by a shift toward androgen predominance including a decrease in sex hormone– binding globulin levels (38,39).”
Heart and Estrogen/progestin Replacement Study (HERS)
Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00010-5 · Cited by 260
The InterAct Consortium (2011) · Diabetologia · doi:10.1007/s00125-011-2182-9 · Cited by 208 · cited 2×
“The participants, methods, study design, and measurements have previously been described (15).”
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study
Ding, E. L., Song, Y., Manson, J. E., Rifai, N., Buring, J. E., & Liu, S. (2007) · Diabetologia · doi:10.1007/s00125-007-0785-y · Cited by 208 · cited 2×
“In postmenopausal women, high endogenous estrogen levels have been associated with an increase rather than a decrease in diabetes risk (36,37).”
Risk factors for incident vertebral fractures in men and women: the Rotterdam Study
van der Klift, M., de Laet, C. E., McCloskey, E. V., Johnell, O., Kanis, J. A., Hofman, A., & Pols, H. A. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040215 · Cited by 197
Early menopause: increased fracture risk at older age
van der Voort, D. J. M., van der Weijer, P. H. M., & Barentsen, R. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1408-1 · Cited by 190
Kalyani, R. R., Franco, M., Dobs, A. S., Ouyang, P., Vaidya, D., Bertoni, A., Gapstur, S. M., & Golden, S. H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0910 · Cited by 179 · cited 2×
“In postmenopausal women, high endogenous estrogen levels have been associated with an increase rather than a decrease in diabetes risk (36,37).”
Cited by
Muka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2415 · Cited by 826
The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis
Golezar, S., Ramezani Tehrani, F., Khazaei, S., Ebadi, A., & Keshavarz, Z. (2019) · Climacteric · doi:10.1080/13697137.2019.1574738 · Cited by 387
Gender differences in glucose homeostasis and diabetes
Mauvais-Jarvis, F. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.08.016 · Cited by 377
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
Diabetes: A metabolic and reproductive disorder in women
Thong, E. P., Codner, E., Laven, J. S. E., & Teede, H. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30345-6 · Cited by 242
Metadata
- Authors
- Brand, J. S., van der Schouw, Y. T., Onland-Moret, N. C., Sharp, S. J., Ong, K. K., Khaw, K.-T., Ardanaz, E., Amiano, P., Boeing, H., Chirlaque, M.-D., Clavel-Chapelon, F., Crowe, F. L., de Lauzon-Guillain, B., Duell, E. J., Fagherazzi, G., Franks, P. W., Grioni, S., Groop, L. C., Kaaks, R., Key, T. J., Nilsson, P. M., Overvad, K., Palli, D., Panico, S., Quirós, J. R., Rolandsson, O., Sacerdote, C., Sánchez, M.-J., Slimani, N., Teucher, B., Tjonneland, A., Tumino, R., van der A, D. L., Feskens, E. J. M., Langenberg, C., Forouhi, N. G., Riboli, E., Wareham, N. J., & The InterAct Consortium
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-03-14
- Volume
- 36
- Issue
- 4
- Pages
- 1012-1019
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2105551601
- Cited by
- 241
- References
- 9
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk. https://app.cochat.ai/papers/10.2337/dc12-1020
- The paper
- Brand, J. S., van der Schouw, Y. T., Onland-Moret, N. C., Sharp, S. J., Ong, K. K., Khaw, K.-T., Ardanaz, E., Amiano, P., Boeing, H., Chirlaque, M.-D., Clavel-Chapelon, F., Crowe, F. L., de Lauzon-Guillain, B., Duell, E. J., Fagherazzi, G., Franks, P. W., Grioni, S., Groop, L. C., Kaaks, R., . . . The InterAct Consortium. (2013). Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk. Diabetes Care. https://doi.org/10.2337/dc12-1020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.